artificial intelligence

The companies aim to create new products enabling faster access to predictive information used in treatment planning for patients with breast cancer.

The company also announced John Leite, the former leader of clinical business development activities at Illumina, had joined the firm as chief business officer.

The project, coordinated by Jena University Hospital and expected to run for five years, aims to address resistance mechanisms in Gram-negative pathogens.

The company's mobile app provides automated COVID-19 screening and directs potential patients to testing locations for confirmatory testing.

Cernostics offers an assay that analyzes whole-slide digital images with multiplexed fluorescence to help interpret Barrett's esophagus patient biopsies.

The firm said the financing enables it to progress with the development of an algorithm that would help detect the most common cancers.

Google Cloud said that the augmented reality microscope would enable access to artificial intelligence models that can help military doctors with cancer detection.

KidneyIntelX is designed to help assess the risk of progressive decline in kidney function in patients with type 2 diabetes and chronic kidney disease.

The financing round was led by Asian private investment firm AT Capital and early-stage deep-tech venture capital fund Elev8.vc.